CHINA-TIANJIN-COVID-19-TAIWANESE-DOCTOR (CN)

CHINA-TIANJIN-COVID-19-TAIWANESE-DOCTOR (CN)

(220126) -- TIANJIN, Jan. 26, 2022 (Xinhua) -- Huang Xinyi (R) collects a swab sample from a resident for COVID-19 test at a testing site in Hedong District of north China's Tianjin, Jan. 20, 2022. Tianjin launched its fourth citywide COVID-19 nucleic acid testing at 6 a.m. on Jan. 20. Doctor Huang Xinyi, who participated in the citywide nucleic acid testing for the second time, was in charge of the testing site of Guanyun Primary School in Hedong District of Tianjin, together with seven colleagues. Born in Kaohsiung of southeast China's Taiwan, Huang Xinyi came to Fujian University of Traditional Chinese Medicine in 2003 to study traditional Chinese medicine. After receiving her doctorate at Tianjin University of Traditional Chinese Medicine in 2015, she became a doctor in the infection department of Tianjin Third Central Hospital. Although the latest resurgence of COVID-19 in Tianj.....

  • Product Code
  • ILEA000887579
  • Registered date
  • 2022/1/26 00:00:00
  • Credit
  • Xinhua / Kyodo News Images
  • Media source
  • Xinhua News Agency.All Rights Reserved
  • Media size
  • 6947 × 4303 pixel
  • Resolution
  • dpi
  • Deployment size
  • 1.83(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    CHINA-TIANJIN-HOSPITAL-DOCTOR-COORDINATOR (CN)

    CHINA-TIANJIN-HOSPITAL-DOCTOR-COORDINATOR (CN)

    (230119) -- TIANJIN, Jan. 19, 2023 (Xinhua) -- Liu Yang (1st R) presides over a coordinating meeting on emergency department's medical treatment at Tianjin Medical University General Hospital in north China's Tianjin, Jan. 17, 2023. Liu is an orthopedist at Tianjin Medical University General Hospital. On Dec. 7, 2022, he was appointed as a coordinator in charge of the symptom triage of patients at the emergency department. Besides resolving problems raised by patients' relatives, Liu and his colleagues have worked to coordinate beds and experts from 36 departments of his hospital in order to effectively treat patients in severe condition. (Xinhua/Li Ran)
      CHINA-GUIZHOU-GUIYANG-COVID-19-TESTING (CN)

      CHINA-GUIZHOU-GUIYANG-COVID-19-TESTING (CN)

      (220905) -- GUIYANG, Sept. 5, 2022 (Xinhua) -- A medical worker takes a swab sample from a resident for nucleic acid test at a community testing site for COVID-19 in Yunyan District of Guiyang, southwest China's Guizhou Province, Sept. 5, 2022. (Xinhua/Yang Wenbin)
        CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

        CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

        (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Bengshan District of Bengbu City, east China's Anhui Province, July 16, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
          CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

          CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

          (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Bengshan District of Bengbu City, east China's Anhui Province, July 16, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
            CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

            CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

            (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Longzihu District of Bengbu City, east China's Anhui Province, July 17, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
              CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

              CHINA-ANHUI-BENGBU-COVID-19-TEST (CN)

              (220717) -- BENGBU, July 17, 2022 (Xinhua) -- A medical worker takes a swab sample from a citizen for nucleic acid testing in Bengshan District of Bengbu City, east China's Anhui Province, July 16, 2022. Bengbu in Anhui has started a new round of mass nucleic acid testing from Saturday to Sunday, as the city races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Zhou Mu)
                CHINA-BEIJING-COVID-19 (CN)

                CHINA-BEIJING-COVID-19 (CN)

                (220513) -- BEIJING, May 13, 2022 (Xinhua) -- A medic takes a swab sample from a child for nucleic acid test at a community in Haidian District of Beijing, capital of China, May 13, 2022. Beijing has started three additional rounds of mass nucleic acid testing in 12 districts from Friday to Sunday, as the Chinese capital races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Ren Chao)
                  CHINA-BEIJING-COVID-19 (CN)

                  CHINA-BEIJING-COVID-19 (CN)

                  (220513) -- BEIJING, May 13, 2022 (Xinhua) -- A medic takes a swab sample from a resident for nucleic acid test at a community in Haidian District of Beijing, capital of China, May 13, 2022. Beijing has started three additional rounds of mass nucleic acid testing in 12 districts from Friday to Sunday, as the Chinese capital races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Ren Chao)
                    CHINA-BEIJING-COVID-19 (CN)

                    CHINA-BEIJING-COVID-19 (CN)

                    (220513) -- BEIJING, May 13, 2022 (Xinhua) -- A medic takes a swab sample from a resident for nucleic acid test at a community in Haidian District of Beijing, capital of China, May 13, 2022. Beijing has started three additional rounds of mass nucleic acid testing in 12 districts from Friday to Sunday, as the Chinese capital races against time to contain the latest resurgence of COVID-19 infections. (Xinhua/Ren Chao)
                      CHINA-HENAN-ZHENGZHOU-NUCLEIC ACID SCREENING (CN)

                      CHINA-HENAN-ZHENGZHOU-NUCLEIC ACID SCREENING (CN)

                      (220507) -- ZHENGZHOU, May 7, 2022 (Xinhua) -- A medical worker takes a swab sample from a resident for a nucleic acid test in Jinshui District of Zhengzhou, central China's Henan Province, May 7, 2022. Zhengzhou has carried out multiple rounds of nucleic acid testing to curb the COVID-19 resurgence. (Xinhua/Hao Yuan)